{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:53:41Z","timestamp":1791266021000,"version":"4.1.0"},"reference-count":40,"publisher":"The Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context:<\/jats:title>\n                  <jats:p>Distinguishing between pituitary [Cushing's disease (CD)] and ectopic causes [ectopic ACTH syndrome (EAS)] of ACTH-dependent Cushing's syndrome can be challenging. Inferior petrosal sinus sampling (IPSS) best discriminates between CD and occult EAS but is a specialized procedure that is not widely available. Identifying adjunctive diagnostic tests may prove useful. In EAS, abnormal processing of the ACTH precursor proopiomelanocortin (POMC) and the accumulation of POMC-derived peptides might be expected and abnormal levels of other neuropeptides may be detected.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective:<\/jats:title>\n                  <jats:p>The objective of the study was to evaluate the diagnostic utility of POMC measurements for distinguishing between CD and occult EAS in patients referred for IPSS. Another objective of the study was to evaluate in parallel the diagnostic utility of another neuropeptide, agouti-related protein (AgRP), because we have observed a 10-fold elevation of AgRP in plasma in a patient with EAS from small-cell lung cancer.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design and Participants:<\/jats:title>\n                  <jats:p>Plasma POMC and AgRP were measured in 38 Cushing's syndrome patients presenting for IPSS, with either no pituitary lesion or a microadenoma on magnetic resonance imaging, and in 38 healthy controls.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>Twenty-seven of 38 patients had CD; 11 of 38 had EAS. The mean POMC was higher in EAS vs CD [54.5 \u00b1 13.0 (SEM) vs 17.2 \u00b1 1.5 fmol\/mL; P &amp;lt; .05]. Mean AgRP was higher in EAS vs CD (280 \u00b1 76 vs 120 \u00b1 16 pg\/mL; P = .01). Although there was an overlap in POMC and AgRP levels between the groups, the POMC levels greater than 36 fmol\/mL (n = 7) and AgRP levels greater than 280 pg\/mL (n = 3) were specific for EAS. When used together, POMC greater than 36 fmol\/mL and\/or AgRP greater than 280 pg\/mL detected 9 of 11 cases of EAS, indicating that elevations in these peptides have a high positive predictive value for occult EAS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions:<\/jats:title>\n                  <jats:p>Expanding upon previous observations of high POMC in EAS, this study specifically demonstrates elevated POMC levels can identify occult ectopic tumors. Elevations in AgRP also favor the diagnosis of EAS, suggesting AgRP should be further evaluated as a potential neuroendocrine tumor marker.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jc.2014-1448","type":"journal-article","created":{"date-parts":[[2014,7,11]],"date-time":"2014-07-11T15:49:24Z","timestamp":1405093764000},"page":"E1838-E1845","source":"Crossref","is-referenced-by-count":40,"title":["Clinical Utility of Plasma POMC and AgRP Measurements in the Differential Diagnosis of ACTH-Dependent Cushing's Syndrome"],"prefix":"10.1210","volume":"99","author":[{"given":"Gabrielle","family":"Page-Wilson","sequence":"first","affiliation":[{"name":"Department of Medicine (G.P.-W., P.U.F., T.P.J., K.M., S.L.W.), New York, New York 10032"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela U.","family":"Freda","sequence":"additional","affiliation":[{"name":"Department of Medicine (G.P.-W., P.U.F., T.P.J., K.M., S.L.W.), New York, New York 10032"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Jacobs","sequence":"additional","affiliation":[{"name":"Department of Medicine (G.P.-W., P.U.F., T.P.J., K.M., S.L.W.), New York, New York 10032"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander G.","family":"Khandji","sequence":"additional","affiliation":[{"name":"Department of Radiology (A.G.K.), New York, New York 10032"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey N.","family":"Bruce","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery (J.N.B.), Columbia University College of Physicians & Surgeons, New York, New York 10032"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra T.","family":"Foo","sequence":"additional","affiliation":[{"name":"Department of Medicine (S.T.F.), Mt Sinai\/St Luke's Roosevelt Hospital, New York, New York 10019"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Meece","sequence":"additional","affiliation":[{"name":"Department of Medicine (G.P.-W., P.U.F., T.P.J., K.M., S.L.W.), New York, New York 10032"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"White","sequence":"additional","affiliation":[{"name":"Faculties of Life Sciences and Medical and Human Sciences (A.W.), University of Manchester, Manchester M13 9PT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon L.","family":"Wardlaw","sequence":"additional","affiliation":[{"name":"Department of Medicine (G.P.-W., P.U.F., T.P.J., K.M., S.L.W.), New York, New York 10032"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071616062231500_B1","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1056\/NEJM199503233321207","article-title":"Cushing's syndrome","volume":"332","author":"Orth","year":"1995","journal-title":"N Engl J Med"},{"key":"2020071616062231500_B2","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJM199206253262609","article-title":"Pancreatic endocrine tumors\u2013the search goes on","volume":"326","author":"Doppman","year":"1992","journal-title":"N Engl J Med"},{"key":"2020071616062231500_B3","first-page":"1780","article-title":"Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome","volume":"82","author":"Aron","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616062231500_B4","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1210\/jc.2004-2527","article-title":"Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health","volume":"90","author":"Ilias","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616062231500_B5","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1210\/jc.2001-011813","article-title":"Management of occult adrenocorticotropin-secreting bronchial carcinoids: limits of endocrine testing and imaging techniques","volume":"88","author":"Loli","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616062231500_B6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ecl.2005.01.009","article-title":"Differential diagnosis and imaging in Cushing's syndrome","volume":"34","author":"Lindsay","year":"2005","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2020071616062231500_B7","first-page":"533","article-title":"The hypoplastic inferior petrosal sinus: a potential source of false-negative results in petrosal sampling for Cushing's disease","volume":"84","author":"Doppman","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616062231500_B8","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1530\/eje.0.1440499","article-title":"Inferior petrosal sinus sampling in the differential diagnosis of Cushing's syndrome: results of an Italian multicenter study","volume":"144","author":"Colao","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"2020071616062231500_B9","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1210\/jc.2003-032249","article-title":"Diagnostic errors after inferior petrosal sinus sampling","volume":"89","author":"Swearingen","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616062231500_B10","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1210\/en.2006-1686","article-title":"Neuropeptide processing and its impact on melanocortin pathways","volume":"148","author":"Pritchard","year":"2007","journal-title":"Endocrinology"},{"key":"2020071616062231500_B11","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0006-291X(71)90620-6","article-title":"Size heterogeneity of immunoreactive human ACTH in plasma and in extracts of pituitary glands and ACTH-producing thymoma","volume":"44","author":"Yalow","year":"1971","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071616062231500_B12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2265.1983.tb03205.x","article-title":"Pro-opiocortin related peptides in human pituitary and ectopic ACTH secreting tumours","volume":"18","author":"Ratter","year":"1983","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071616062231500_B13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2265.1994.tb02468.x","article-title":"ACTH precursors characterize the ectopic ACTH syndrome","volume":"40","author":"Stewart","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071616062231500_B14","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1172\/JCI107357","article-title":"Biologic and immunologic characterization and physical separation of ACTH and ACTH fragments in the ectopic ACTH syndrome","volume":"52","author":"Orth","year":"1973","journal-title":"J Clin Invest"},{"key":"2020071616062231500_B15","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1210\/jcem-67-6-1272","article-title":"Direct measurement of the precursors of adrenocorticotropin in human plasma by two-site immunoradiometric assay","volume":"67","author":"Crosby","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616062231500_B16","first-page":"4272","article-title":"High plasma proopiomelanocortin in aggressive adrenocorticotropin-secreting tumors","volume":"81","author":"Raffin-Sanson","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616062231500_B17","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1507\/endocrj.52.743","article-title":"Malignant gastric carcinoid causing ectopic ACTH syndrome: discrepancy of plasma ACTH levels measured by different immunoradiometric assays","volume":"52","author":"Tsuchiya","year":"2005","journal-title":"Endocr J"},{"key":"2020071616062231500_B18","first-page":"497","article-title":"Impaired processing of proopiomelanocortin in corticotroph macroadenomas","volume":"81","author":"Gibson","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616062231500_B19","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1172\/JCI112184","article-title":"Altered proopiomelanocortin gene expression in adrenocorticotropin-producing nonpituitary tumors. Comparative studies with corticotropic adenomas and normal pituitaries","volume":"76","author":"de Keyzer","year":"1985","journal-title":"J Clin Invest"},{"key":"2020071616062231500_B20","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0960-0760(92)90072-Q","article-title":"Unrestrained production of proopiomelanocortin (POMC) and its peptide fragments by pituitary corticotroph adenomas in Cushing's disease","volume":"43","author":"Bertagna","year":"1992","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2020071616062231500_B21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1023\/B:PITU.0000011172.26649.df","article-title":"Characterisation of ACTH related peptides in ectopic Cushing's syndrome","volume":"6","author":"Oliver","year":"2003","journal-title":"Pituitary"},{"key":"2020071616062231500_B22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1126\/science.278.5335.135","article-title":"Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein","volume":"278","author":"Ollmann","year":"1997","journal-title":"Science"},{"key":"2020071616062231500_B23","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM199109263251301","article-title":"Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome","volume":"325","author":"Oldfield","year":"1991","journal-title":"N Engl J Med"},{"key":"2020071616062231500_B24","first-page":"835","article-title":"Differential release of proopiomelanocortin-derived peptides from the human pituitary: evidence from a panel of two-site immunoradiometric assays","volume":"78","author":"Gibson","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616062231500_B25","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1523\/JNEUROSCI.5332-09.2010","article-title":"Rapid glucocorticoid receptor-mediated inhibition of hypothalamic-pituitary-adrenal ultradian activity in healthy males","volume":"30","author":"Russell","year":"2010","journal-title":"J Neurosci"},{"key":"2020071616062231500_B26","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1038\/bjc.2013.112","article-title":"Neuroendocrine and epithelial phenotypes in small-cell lung cancer: implications for metastasis and survival in patients","volume":"108","author":"Stovold","year":"2013","journal-title":"Br J Cancer"},{"key":"2020071616062231500_B27","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1210\/jc.2012-2309","article-title":"Cerebrospinal fluid levels of leptin, proopiomelanocortin, and agouti-related protein in human pregnancy: evidence for leptin resistance","volume":"98","author":"Page-Wilson","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616062231500_B28","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1210\/en.2009-0853","article-title":"Effects of estradiol on cerebrospinal fluid levels of agouti-related protein in ovariectomized rhesus monkeys","volume":"151","author":"Xiao","year":"2010","journal-title":"Endocrinology"},{"key":"2020071616062231500_B29","first-page":"1057","article-title":"The ectopic ACTH syndrome","volume":"25","author":"Liddle","year":"1965","journal-title":"Cancer Res"},{"key":"2020071616062231500_B30","first-page":"2430","article-title":"Elevated levels of adrenocorticotropin (ACTH) precursors in post-adrenalectomy Cushing's disease and their regulation by glucocorticoids","volume":"80","author":"Ray","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616062231500_B31","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1093\/annonc\/12.suppl_2.S83","article-title":"Ectopic ACTH syndrome: molecular bases and clinical heterogeneity","volume":"12","author":"Terzolo","year":"2001","journal-title":"Ann Oncol"},{"key":"2020071616062231500_B32","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2265.1989.tb01294.x","article-title":"Corticotrophin-like intermediary lobe peptide as a marker of alternate pro-opiomelanocortin processing in ACTH-producing non-pituitary tumours","volume":"31","author":"Vieau","year":"1989","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071616062231500_B33","first-page":"1503","article-title":"Expression of the prohormone convertase PC2 correlates with the presence of corticotropin-like intermediate lobe peptide in human adrenocorticotropin-secreting tumors","volume":"79","author":"Vieau","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616062231500_B34","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1210\/en.2005-1373","article-title":"Agouti-related protein is posttranslationally cleaved by proprotein convertase 1 to generate agouti-related protein (AGRP)83\u2013132: interaction between AGRP83\u2013132 and melanocortin receptors cannot be influenced by syndecan-3","volume":"147","author":"Creemers","year":"2006","journal-title":"Endocrinology"},{"key":"2020071616062231500_B35","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1055\/s-2005-872895","article-title":"Agouti related protein (AgRP) is upregulated in Cushing's syndrome","volume":"113","author":"Dhillo","year":"2005","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2020071616062231500_B36","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.mce.2006.12.025","article-title":"Role of Agouti-related protein in adrenal steroidogenesis","volume":"265\u2013266","author":"Doghman","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"2020071616062231500_B37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0006-8993(02)03674-0","article-title":"Effects of adrenalectomy on AGRP, POMC, NPY and CART gene expression in the basal hypothalamus of fed and fasted rats","volume":"958","author":"Savontaus","year":"2002","journal-title":"Brain Res"},{"key":"2020071616062231500_B38","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0006-291X(02)02991-1","article-title":"Agouti-related protein has an inhibitory paracrine role in the rat adrenal gland","volume":"301","author":"Dhillo","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071616062231500_B39","first-page":"647","article-title":"The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states","volume":"19","author":"Newell-Price","year":"1998","journal-title":"Endocr Rev"},{"key":"2020071616062231500_B40","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1210\/jcem.78.2.8106630","article-title":"A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome","volume":"78","author":"Dichek","year":"1994","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/99\/10\/E1838\/9107990\/jcem1838.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/99\/10\/E1838\/9107990\/jcem1838.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T03:06:03Z","timestamp":1594955163000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/99\/10\/E1838\/2836150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,1]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2014-1448","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,1]]}}}